Ident. | Authors (with country if any) | Title |
---|
000275 (2015) |
Raffaella Franciotti [Italie] ; Stefano Delli Pizzi [Italie] ; Bernardo Perfetti [Italie] ; Armando Tartaro [Italie] ; Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Luca Weis [Italie] ; Roberta Biundo [Italie] ; Angelo Antonini [Italie] ; Marco Onofrj [Italie] | Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy. |
000644 (2014) |
Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Emanuele Persichetti [Italie] ; Paolo Eusebi [Italie] ; Shiji Varghese [Émirats arabes unis] ; Mohammad M. Qureshi [Émirats arabes unis] ; Andrea Dardis [Italie] ; Marta Deganuto [Italie] ; Claudia De Carlo [Italie] ; Anna Castrioto [Italie] ; Chiara Balducci [Italie] ; Silvia Paciotti [Italie] ; Nicola Tambasco [Italie] ; Bruno Bembi [Italie] ; Laura Bonanni [Italie] ; Marco Onofrj [Italie] ; Aroldo Rossi [Italie] ; Tommaso Beccari [Italie] ; Omar El-Agnaf [Émirats arabes unis, Arabie saoudite] ; Paolo Calabresi [Italie] | Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease |
000980 (2013) |
Marco Onofrj [Italie] | Functional or somatoform disorders in Parkinson's disease? |
000F56 (2012) |
Fabrizio Stocchi [Italie] ; Rupam Borgohain ; Marco Onofrj ; Anthony H V. Schapira ; Mohit Bhatt ; Valentina Lucini ; Rodolfo Giuliani ; Ravi Anand | A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients. |
001279 (2012) |
Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse] | A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients |
001471 (2011) |
Marco Onofrj [Italie] ; Laura Bonanni [Italie] ; Astrid Thomas [Italie] | Reply: Is cognition key in paradoxical kinesia? |
001812 (2011) |
Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Gianni Bellomo [Italie] ; David Giannandrea [Italie] ; Claudia De Carlo [Italie] ; Mohamed M. Qureshi [Émirats arabes unis] ; Mustafa T. Ardah [Émirats arabes unis] ; Shiji Varghese [Émirats arabes unis] ; Laura Bonanni [Italie] ; Barbara Borroni [Italie] ; Nicola Tambasco [Italie] ; Paolo Eusebi [Italie] ; Aroldo Rossi [Italie] ; Marco Onofrj [Italie] ; Alessandro Padovani [Italie] ; Paolo Calabresi [Italie] ; Omar El-Agnaf [Émirats arabes unis] | Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias |
001C64 (2011) |
Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Gianni Bellomo [Italie] ; David Giannandrea [Italie] ; Claudia De Carlo [Italie] ; Mohamed M. Qureshi [Émirats arabes unis] ; Mustafa T. Ardah [Émirats arabes unis] ; Shiji Varghese [Émirats arabes unis] ; Laura Bonanni [Italie] ; Barbara Borroni [Italie] ; Nicola Tambasco [Italie] ; Paolo Eusebi [Italie] ; Aroldo Rossi [Italie] ; Marco Onofrj [Italie] ; Alessandro Padovani [Italie] ; Paolo Calabresi [Italie] ; Omar El-Agnaf [Émirats arabes unis] | Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias |
001E57 (2010) |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
001F59 (2010) |
Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Marco Onofrj [Italie] | Paradoxical kinesia in parkinsonian patients surviving earthquake |
002436 (2010) |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study |
002504 (2010) |
Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Marco Onofrj [Italie] | Paradoxical Kinesia in Parkinsonian Patients Surviving Earthquake |
003A67 (2007) |
Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Vincenzo Scorrano [Italie] ; Marco Onofrj [Italie] | Task‐specific lower lip dystonia due to mantra recitation |
003E04 (2007) |
Astrid Thomas [Italie] ; Laura Bonanni [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie] ; Marco Onofrj [Italie] | Dopa‐responsive pseudo‐orthostatic tremor in parkinsonism |
003F05 (2007) |
Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Sara Varanese [Italie] ; Vincenzo Scorrano [Italie] ; Marco Onofrj [Italie] | Botulinum toxin treatment of lateral axial dystonia in parkinsonism |
004296 (2007) |
Astrid Thomas [Italie] ; Laura Bonanni [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie] ; Marco Onofrj [Italie] | Dopa-responsive pseudo-orthostatic tremor in parkinsonism |
004358 (2007) |
Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Sara Varanese [Italie] ; Vincenzo Scorrano [Italie] ; Marco Onofrj [Italie] | Botulinum Toxin Treatment of Lateral Axial Dystonia in Parkinsonism |
004667 (2006) |
Werner Poewe [Autriche] ; Erik Wolters [Pays-Bas] ; Murat Emre [Turquie] ; Marco Onofrj [Italie] ; Chuanchieh Hsu [États-Unis] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis] | Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study |
004B23 (2006) |
Werner Poewe [Autriche] ; Erik Wolters [Pays-Bas] ; Murat Emre [Turquie] ; Marco Onofrj [Italie] ; Chuanchieh Hsu [États-Unis] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis] | Long-term benefits of rivastigmine in dementia associated with parkinson's disease : An active treatment extension study |
005120 (2005) |
Astrid Thomas [Italie] ; Marco Onofrj [Italie] | Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal |
005D01 (2003) |
Marco Onofrj [Italie] ; Anna Lisa Luciano [Italie] ; Diego Iacono [Italie] ; Astrid Thomas [Italie] ; Fabrizio Stocchi [Italie] ; Franco Papola [Italie] ; Domenico Adorno [Italie] ; Rocco Di Mascio [Italie] | HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease |